The European Patent Office has granted a patent for the XCaps dry powder inhaler, Hovione has announced. The company filed for the patent in June 2011.
Hovione VP Peter Villax, who co-invented the inhaler, commented, “We give our customers an edge in speed of development because we are perhaps the only independent company developing DPIs with expertise in every aspect of the inhaled drug development process. Granting of the European Patent on the XCaps inhaler, within 30 months after initial filing, underpins Hovione’s capabilities in innovation and intellectual property management, to successfully design, develop and deliver innovative products, namely, a quality inhalation device, addressing a market need.”
According to the company, the two-component XCaps DPI can produce lung fractions of great than 70% and the company “is looking for partners willing to incorporate the XCaps into their inhalation drug development.”
Read the Hovione press release.
